mRNAs have recently emerged as a therapeutic approach, notably with mRNA vaccines for SARS-CoV2. Many research groups aim to better understand mRNA technology and its potential applications. A current challenge is the lack of control over mRNA translation into proteins, hindering therapy development.
Flash-Caps offer a solution, controlling mRNA studies with light without altering its natural structure or sequence. Light serves as a precise external trigger, compatible with standard mRNA production and application methods, making Flash-Caps valuable for all mRNA research groups and companies.
We are looking for collaborators who would like to try Flash-Caps. If you are working in basic research or development using mRNA technology, we would be delighted to optimize Flash-Caps for your field – all research projects are welcome. If you are interested please sent an e-mail to Flash.Caps[AT]cup.lmu.de.
